AstraZeneca pauses COVID-19 vaccine trial over safety concerns
- 4 years ago
아스트라제네카, 코로나19백신 임상3상 중단…"심각질환 발견"
UK drugmaker AstraZeneca has paused all clinical trials of its COVID-19 vaccine after one person suffered a suspected serious adverse reaction.
In a statement Tuesday,... the company voluntarily put the late-stage trial on hold to review the related data, but added it was working to ensure there wouldn't be a significant delay.
The vaccine being developed by AstraZeneca and Oxford University researchers had been on track to become one of the first to deliver results from a large trial.
Despite the urgency to contain the pandemic, nine leading vaccine developers in the U.S. and Europe have pledged to uphold safety standards for their vaccine candidates.
UK drugmaker AstraZeneca has paused all clinical trials of its COVID-19 vaccine after one person suffered a suspected serious adverse reaction.
In a statement Tuesday,... the company voluntarily put the late-stage trial on hold to review the related data, but added it was working to ensure there wouldn't be a significant delay.
The vaccine being developed by AstraZeneca and Oxford University researchers had been on track to become one of the first to deliver results from a large trial.
Despite the urgency to contain the pandemic, nine leading vaccine developers in the U.S. and Europe have pledged to uphold safety standards for their vaccine candidates.